594836-56-3Relevant academic research and scientific papers
INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
-
Page/Page column 267; 268, (2021/01/29)
The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
HETEROARYL OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 58, (2016/07/05)
The present invention is directed to heteroaryl compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
